| Jul 31 |
Precision BioSciences Q2 2024 Earnings Preview
|
| Jul 31 |
Precision BioSciences to Participate in Upcoming August Investor Conferences
|
| Jul 29 |
Precision BioSciences to Report Second Quarter Results on August 1, 2024
|
| Jul 8 |
Precision BioSciences to Present at the Upcoming JonesTrading Healthcare Seaside Summit
|
| Jul 1 |
Precision BioSciences joins Russell Microcap Index
|
| Jul 1 |
Precision BioSciences Announces its Addition to the Russell Microcap® Index
|
| Jun 27 |
Precision BioSciences Announces Presentation at UMDF Mitochondrial Medicine 2024 Supporting Advancement of PBGENE-PMM Program Towards IND and/or CTA in 2025
|
| Jun 20 |
Precision BioSciences Expands Hepatitis Scientific Advisory Board with Addition of World-Class Clinical Investigators Mark Sulkowski, M.D. and Jordan Feld, M.D., MPH, as PBGENE-HBV Program Nears Clinical Readiness
|
| Jun 5 |
Precision BioSciences Presents New Preclinical Safety Data for PBGENE-HBV Clinical Candidate at the European Association for the Study of the Liver Congress
|
| May 30 |
Precision BioSciences to Participate in Upcoming June Investor Conferences
|
